29 related articles for article (PubMed ID: 38571454)
1. [Prostate cancer screening-current overview].
De Vrieze M; Hübner A; Al-Monajjed R; Albers P; Radtke JP; Schimmöller L; Boschheidgen M
Radiologie (Heidelb); 2024 Jun; 64(6):479-487. PubMed ID: 38743100
[TBL] [Abstract][Full Text] [Related]
2. Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years.
Pinsky PF; Prorok PC; Yu K; Kramer BS; Black A; Gohagan JK; Crawford ED; Grubb RL; Andriole GL
Cancer; 2017 Feb; 123(4):592-599. PubMed ID: 27911486
[TBL] [Abstract][Full Text] [Related]
3. Factors Influencing Prostate Cancer Screening Intentions in Lebanese Men.
Hejase R; Saleh AM; Abdel-Aziz HR; Vellaiyan A; AlOmari AK; AlOmari AA
Asian Pac J Cancer Prev; 2024 Mar; 25(3):963-970. PubMed ID: 38546078
[TBL] [Abstract][Full Text] [Related]
4. Modifying and personalizing prostate cancer screening.
Stone A; Goldberg H
Transl Androl Urol; 2024 May; 13(5):899-901. PubMed ID: 38855594
[No Abstract] [Full Text] [Related]
5. Digital Rectal Examination Is Not a Useful Screening Test for Prostate Cancer.
Krilaviciute A; Becker N; Lakes J; Radtke JP; Kuczyk M; Peters I; Harke NN; Debus J; Koerber SA; Herkommer K; Gschwend JE; Meissner VH; Benner A; Seibold P; Kristiansen G; Hadaschik B; Arsov C; Schimmöller L; Giesel FL; Antoch G; Makowski M; Wacker F; Schlemmer HP; Kaaks R; Albers P
Eur Urol Oncol; 2023 Dec; 6(6):566-573. PubMed ID: 37806841
[TBL] [Abstract][Full Text] [Related]
6. Prediction of prostate cancer risk: the role of prostate volume and digital rectal examination in the ERSPC risk calculators.
Roobol MJ; van Vugt HA; Loeb S; Zhu X; Bul M; Bangma CH; van Leenders AG; Steyerberg EW; Schröder FH
Eur Urol; 2012 Mar; 61(3):577-83. PubMed ID: 22104592
[TBL] [Abstract][Full Text] [Related]
7. The role of the digital rectal examination as diagnostic test for prostate cancer detection in obese patients.
Dell'Atti L
J BUON; 2015; 20(6):1601-5. PubMed ID: 26854458
[TBL] [Abstract][Full Text] [Related]
8. Digital rectal examination is barrier to population-based prostate cancer screening.
Nagler HM; Gerber EW; Homel P; Wagner JR; Norton J; Lebovitch S; Phillips JL
Urology; 2005 Jun; 65(6):1137-40. PubMed ID: 15922431
[TBL] [Abstract][Full Text] [Related]
9. Is it time to abandon the digital rectal examination? Lessons from the PLCO Cancer Screening Trial and peer-reviewed literature.
Cui T; Kovell RC; Terlecki RP
Curr Med Res Opin; 2016 Oct; 32(10):1663-1669. PubMed ID: 27264113
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of an imageless machine-learning algorithm for the initial screening of prostate cancer.
Martelin N; De Witt B; Chen B; Eschwège P
Prostate; 2024 Jun; 84(9):842-849. PubMed ID: 38571454
[TBL] [Abstract][Full Text] [Related]
11. Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis.
Matsukawa A; Yanagisawa T; Bekku K; Kardoust Parizi M; Laukhtina E; Klemm J; Chiujdea S; Mori K; Kimura S; Fazekas T; Miszczyk M; Miki J; Kimura T; Karakiewicz PI; Rajwa P; Shariat SF
Eur Urol Oncol; 2024 Jan; ():. PubMed ID: 38182488
[TBL] [Abstract][Full Text] [Related]
12. Need for and relevance of prostate cancer screening in Nigeria.
Akinremi T; Adeniyi A; Olutunde A; Oduniyi A; Ogo C
Ecancermedicalscience; 2014; 8():457. PubMed ID: 25228913
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]